ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag biotechnology neuroscience infectious disease

Diagram tracking changes in gene expression
Ticker Tape Technology Records Cell History
Danielle Gerhard, PhD | Oct 2, 2023 | 1 min read
Researchers developed a novel protein fiber that tracks transcriptional events over time in living cells. This could shine a light on gene regulation during development or after cellular perturbations.
Photo of Ankara Jain in his lab
Ankur Jain Explores RNA Aggregations in Neurodegenerative Disease
Hannah Thomasy, PhD | Oct 3, 2022 | 3 min read
The MIT biologist studies how RNA molecules self-assemble and the role these accumulations may play in diseases such as ALS and Huntington’s.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Scanning electron micrograph (SEM) of the unicellular yeast Saccharomyces cerevisiae, known as Baker's or Brewer's yeast.
Yeast Models Provide New Insights into Neurodegenerative Diseases
Mahlon Collins | Oct 1, 2021 | 10+ min read
The single-celled fungus allows researchers to study Alzheimer’s, Parkinson’s, ALS and other brain diseases with unparalleled speed and scale.
Infectious Diseases Expert To Head National AIDS Unit
The Scientist Staff | Sep 17, 1989 | 5 min read
The National Institute of Allergy and Infectious Diseases has named George W. Counts as head of the newly established Clinical Research Management Branch in the Treatment Research Program of NIAID’s Division of AIDS. Prior to the appointment, Counts, 54, had been a professor of medicine at the University of Washington, Seattle, since 1975. He also served as director of the Clinical Microbiology Laboratory at the Fred Hutchinson Cancer Research Center in Seat- tle from 1985 to 1989. Co
a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Biotechnology's Prospects A Year After The Crash
Robert Buderi | Oct 2, 1988 | 7 min read
Right after Black Monday, analysts said venture capital would dry up. This tour-page special report shows the still thriving field finding money in new places but facing increased scrutiny. CAMBRIDGE, MASS.—One year ago this month the stock market suffered its worst decline since 1929. In the wake of Black Monday, pundits prophesied dire consequences—for the economy in general and for corporate and entrepreneurial science and technology in particular. Corporate R&D budgets would
Inspired by Nature
Daniel Cossins | Aug 1, 2015 | 10+ min read
Researchers are borrowing designs from the natural world to advance biomedicine.
Blood-Brain Barrier Booming As A Source Of New Biotechnology Research Challenges
Karen Young Kreeger | Sep 15, 1996 | 8 min read
Industry observers predict increased opportunities as firms set their sights on novel techniques for drug delivery. 'HUGE EXPLOSION: Many potentially therapeutic brain molecules are a boon, asserts Richard Pops. Finding ways to sneak therapeutic drugs past the seemingly impenetrable blood-brain barrier -- a tightly bound wall of endothelial cells that protects the brain from pathogens and other substances -- is keeping a small cadre of biotech firms busy. Researchers at these companies, as

Run a Search

ADVERTISEMENT